Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Geier

Showing results (21-30 of 249) with videos related to

Pageof 25
Sort By:
Viruses|January 25, 2013
Host genetic variants in the pathogenesis of hepatitis CMonika Rau, Katharina Baur, Andreas Geier
Gut|April 22, 2018
Manipulation of the gut-liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?Daniel Jahn, Marco Marzioni, Andreas Geier
MMW Fortschritte Der Medizin|September 11, 2012
[Current therapeutic strategies for hepatocellular carcinoma]Andreas Geier, Erik Schadde, Beat Müllhaupt
Deutsches Arzteblatt International|March 24, 2015
In replyJohannes Weiß, Monika Rau, Andreas Geier
Nature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael Trauner
Deutsche Medizinische Wochenschrift (1946)|July 17, 2015
[Non-alcoholic fatty liver disease (NAFLD)]Monika Rau, Johannes Weiss, Andreas Geier
World Journal of Gastroenterology|January 23, 2023
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?Christoph G Dietrich, Andreas Geier, Uta Merle
The New England Journal of Medicine|July 27, 2002
Bosentan for pulmonary hypertensionChristoph G Dietrich, Andreas Geier, Frank Lammert
World Journal of Gastroenterology|January 13, 2016
Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceChristoph G Dietrich, Oliver Götze, Andreas Geier
Hepatology (Baltimore, Md.)|February 26, 2003
Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levelsAndreas Geier, Christoph G Dietrich, Carsten Gartung
Pageof 25

Showing results (21-30 of 249) with videos related to

Sort By:
Pageof 25
Viruses|January 25, 2013
Host genetic variants in the pathogenesis of hepatitis CMonika Rau, Katharina Baur, Andreas Geier
Gut|April 22, 2018
Manipulation of the gut-liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?Daniel Jahn, Marco Marzioni, Andreas Geier
MMW Fortschritte Der Medizin|September 11, 2012
[Current therapeutic strategies for hepatocellular carcinoma]Andreas Geier, Erik Schadde, Beat Müllhaupt
Deutsches Arzteblatt International|March 24, 2015
In replyJohannes Weiß, Monika Rau, Andreas Geier
Nature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael Trauner
Deutsche Medizinische Wochenschrift (1946)|July 17, 2015
[Non-alcoholic fatty liver disease (NAFLD)]Monika Rau, Johannes Weiss, Andreas Geier
World Journal of Gastroenterology|January 23, 2023
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?Christoph G Dietrich, Andreas Geier, Uta Merle
The New England Journal of Medicine|July 27, 2002
Bosentan for pulmonary hypertensionChristoph G Dietrich, Andreas Geier, Frank Lammert
World Journal of Gastroenterology|January 13, 2016
Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceChristoph G Dietrich, Oliver Götze, Andreas Geier
Hepatology (Baltimore, Md.)|February 26, 2003
Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levelsAndreas Geier, Christoph G Dietrich, Carsten Gartung
Pageof 25